[Elsevier] Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study

yaya133 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-10 01:28
Reward20points

DOI: 10.1016/S0140-6736(26)00865-2
URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00865-2/abstract

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    580


Daily Top Contributors

Return to the list